设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2024 年第 5 期 第 0 卷

冠心病合并糖尿病患者经皮冠状动脉介入术后支架内再狭窄危险因素的研究进展

Research progress on risk factors of in-stent restenosis in patients with coronary atherosclerotic heart disease and diabetes mellitus after percutaneous coronary intervention

作者:罗鸿池1 马涵英1 韩红亚2 李亚冬1 刘晓丽2 赵铁夫1

英文作者:Luo Hongchi1 Ma Hanying1 Han Hongya2 Li Yadong1 Liu Xiaoli2 Zhao Tiefu1

单位:1首都医科大学附属北京安贞医院全科医疗科,北京100029;2首都医科大学附属北京安贞医院老年心血管病中心,北京100029

英文单位:1Department of General Medicine Beijing Anzhen Hospital Capital Medical University Beijing 100029 China; 2Elderly Cardiovascular Center Beijing Anzhen Hospital Capital Medical University Beijing 100029 China

关键词:冠心病(冠状动脉粥样硬化性心脏病);糖尿病;支架内再狭窄;经皮冠状动脉介入;危险因素

英文关键词:Coronaryatheroscleroticheartdisease;Diabetesmellitus;In-stentrestenosis;Percutaneouscoronaryintervention;Riskfactors

  • 摘要:
  • 冠心病(冠状动脉粥样硬化性心脏病)合并糖尿病患者冠状动脉支架内再狭窄率显著高于未合并糖尿病患者。其特征以糖代谢异常、血糖波动、胰岛素抵抗为核心,且往往伴发高脂血症、高尿酸血症、凝血及纤维蛋白溶解指标异常、慢性炎症等,这些因素直接或间接影响了血管内皮功能,促使平滑肌增生、凝血异常等,并最终导致再狭窄的发生。本综述主要针对糖尿病合并冠心病患者经皮冠状动脉介入术后支架内再狭窄危险因素的研究进行总结探讨,以期为临床降低支架内再狭窄发生率及预防不良心血管事件的发生提供参考依据。

  • The rate of in-stent restenosis in patients with coronary atherosclerotic heart disease and diabetes mellitus is significantly higher than that in patients without diabetes mellitus. It is characterized by abnormal glucose metabolism, blood glucose fluctuation, insulin resistance as the core, and is often accompanied by hyperlipidemia, hyperuricemia, abnormal coagulation and fibrinolysis indicators, chronic inflammation, etc. These factors directly or indirectly affect vascular endothelial function, promote smooth muscle proliferation, abnormal coagulation, and ultimately lead to the occurrence of restenosis. This review mainly summarizes and discusses the research on the risk factors of in-stent restenosis after percutaneous coronary intervention in patients with diabetes mellitus and coronary atherosclerotic heart disease, in order to provide a reference for reducing the incidence of in-stent restenosis and preventing the occurrence of adverse cardiovascular events.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭